These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 36113105)
21. Exploring the impact of the COVID-19 pandemic on syringe services programs in rural Kentucky. Glick JL; Grieb SM; Harris SJ; Weir BW; Smith KC; Puryear T; Hamilton White R; Allen ST Harm Reduct J; 2022 May; 19(1):47. PubMed ID: 35590373 [TBL] [Abstract][Full Text] [Related]
22. Factors associated with perceived ease of access to syringes in Appalachian North Carolina. Carpenter DM; Zule WA; Hennessy CM; Evon DM; Hurt CB; Ostrach B J Rural Health; 2023 Jan; 39(1):212-222. PubMed ID: 35819251 [TBL] [Abstract][Full Text] [Related]
23. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs. Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339 [TBL] [Abstract][Full Text] [Related]
24. Injection Behaviors and Use of Syringe Service Programs over Time among People Who Inject Drugs in Baltimore, Maryland. German D; Glick JL; Yenokyan K; Genberg B; Sawyer A; Gribbin M; Flynn C Subst Use Misuse; 2024; 59(5):651-664. PubMed ID: 38115628 [No Abstract] [Full Text] [Related]
25. HIV Infection and HIV-Associated Behaviors Among Persons Who Inject Drugs - 23 Metropolitan Statistical Areas, United States, 2018. Handanagic S; Finlayson T; Burnett JC; Broz D; Wejnert C; MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(42):1459-1465. PubMed ID: 34673746 [TBL] [Abstract][Full Text] [Related]
26. Factors Associated with Sterile Syringe Acquisition among People Who Inject Drugs in West Virginia. Allen ST; Mazhnaya A; O'Rourke A; White RH; Wedlock P; Grieb SM; Kilkenny ME; Walls M; Sherman SG Subst Use Misuse; 2021; 56(12):1776-1784. PubMed ID: 34311667 [TBL] [Abstract][Full Text] [Related]
27. Police officer attitudes towards syringe services programming. Sightes E; Ray B; Paquet SR; Bailey K; Huynh P; Weintraut M Drug Alcohol Depend; 2019 Dec; 205():107617. PubMed ID: 31707271 [TBL] [Abstract][Full Text] [Related]
28. Serious Mental Illness Among Young People Who Inject Drugs: An Assessment of Injection Risks and Healthcare Use. Adams M; Sionean C; Broz D; Lewis R; Wejnert C; J Infect Dis; 2020 Sep; 222(Suppl 5):S401-S409. PubMed ID: 32877554 [TBL] [Abstract][Full Text] [Related]
29. The Impact of Syringe Services Program Policy on Risk Behaviors Among Persons Who Inject Drugs in 3 US Cities, 2005-2015. Nassau T; Al-Tayyib A; Robinson WT; Shinefeld J; Brady KA Public Health Rep; 2020; 135(1_suppl):138S-148S. PubMed ID: 32735193 [TBL] [Abstract][Full Text] [Related]
30. Preventing HIV and Hepatitis Infections Among People Who Inject Drugs: Leveraging an Indiana Outbreak Response to Break the Impasse. Crowley JS; Millett GA AIDS Behav; 2017 Apr; 21(4):968-972. PubMed ID: 28220312 [TBL] [Abstract][Full Text] [Related]
31. Implementation of Syringe Services Programs to Prevent Rapid Human Immunodeficiency Virus Transmission in Rural Counties in the United States: A Modeling Study. Goedel WC; King MRF; Lurie MN; Galea S; Townsend JP; Galvani AP; Friedman SR; Marshall BDL Clin Infect Dis; 2020 Mar; 70(6):1096-1102. PubMed ID: 31143944 [TBL] [Abstract][Full Text] [Related]
33. Application of machine learning algorithms for localized syringe services program policy implementation - Florida, 2017. Bartholomew TS; Tookes HE; Spencer EC; Feaster DJ Ann Med; 2022 Dec; 54(1):2137-2150. PubMed ID: 35900201 [TBL] [Abstract][Full Text] [Related]
34. "They look at us like junkies": influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Muncan B; Walters SM; Ezell J; Ompad DC Harm Reduct J; 2020 Jul; 17(1):53. PubMed ID: 32736624 [TBL] [Abstract][Full Text] [Related]
35. Weathering the Storm: Syringe Services Program Laws and Human Immunodeficiency Virus During the COVID-19 Pandemic. Jackson H; Dunphy C; Grist MB; Jiang X; Xu L; Guy GP; Salvant-Valentine S J Acquir Immune Defic Syndr; 2023 Dec; 94(5):395-402. PubMed ID: 37949442 [TBL] [Abstract][Full Text] [Related]
36. Shifting the paradigm: physician-authorized, student-led efforts to provide harm reduction services amidst legislative opposition. McMullen TP; Naeim M; Newark C; Oliphant H; Suchard J; Banimahd F Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):27. PubMed ID: 33761954 [TBL] [Abstract][Full Text] [Related]
37. Syringe Services Programs to Reduce Intravenous Disease Transmission in Substance Use Disorders. Roberts HH; Stone M; Isac AJ Nurs Clin North Am; 2023 Jun; 58(2):243-256. PubMed ID: 37105658 [TBL] [Abstract][Full Text] [Related]
38. Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida. Bartholomew TS; Feaster DJ; Patel H; Forrest DW; Tookes HE J Subst Abuse Treat; 2021 Aug; 127():108344. PubMed ID: 34134863 [TBL] [Abstract][Full Text] [Related]
39. Differential access to syringe exchange and other prevention activities among people who inject drugs in rural and urban areas of Puerto Rico. Welch-Lazoritz M; Habecker P; Dombrowski K; Rivera Villegas A; Davila CA; Rolón Colón Y; Miranda De León S Int J Drug Policy; 2017 May; 43():16-22. PubMed ID: 28160735 [TBL] [Abstract][Full Text] [Related]
40. Acceptability and Effectiveness of Hepatitis C Care at Syringe Service Programs for People Who Inject Drugs in New York City. Muncan B; Jordan AE; Perlman DC; Frank D; Ompad DC; Walters SM Subst Use Misuse; 2021; 56(5):728-737. PubMed ID: 33682610 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]